Time to disease progressionMedian · clinically localized prostate cancer
Radical prostatectomy probably leads to lower time to disease progressionMedian compared with active monitoring (moderate certainty).
1 finding from 1 review
Incidence of metastatic diseaseMedian · clinically localized prostate cancer
Radical prostatectomy probably leads to lower incidence of metastatic diseaseMedian compared with active monitoring (moderate certainty).
1 finding from 1 review
Health‐related quality of life · clinically localized prostate cancer
1 finding from 1 review
Urinary function · clinically localized prostate cancer
1 finding from 1 review
Effect on later sexual function · clinically localized prostate cancer
1 finding from 1 review
Time to death from any causeMedian · clinically localized prostate cancer
Radical prostatectomy showed no clear difference in time to death from any causeMedian compared with active monitoring (moderate certainty).
1 finding from 1 review
Time to death from prostate cancerMedian · clinically localized prostate cancer
Radical prostatectomy showed no clear difference in time to death from prostate cancerMedian compared with active monitoring (moderate certainty).
1 finding from 1 review
Perinatal death or severe morbidity · women for whom a decision had been made to deliver by caesarean section for suspected fetal distress based on FHR monitoring
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Fetal or neonatal mortality · women for whom a decision had been made to deliver by caesarean section for suspected fetal distress based on FHR monitoring
Summary of findings for IV hexoprenaline showed no clear difference in fetal or neonatal mortality compared with no tocolytic agent, whilst awaiting emergency delivery (low certainty).
1 finding from 1 review
Caesarean section · women for whom a decision had been made to deliver by caesarean section for suspected fetal distress based on FHR monitoring
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Apgar score less than 7 at 5 minutes · women for whom a decision had been made to deliver by caesarean section for suspected fetal distress based on FHR monitoring
Summary of findings for IV hexoprenaline showed no clear difference in 5‐minute Apgar score < 7 compared with no tocolytic agent, whilst awaiting emergency delivery (low certainty).
1 finding from 1 review
Low umbilical artery pH (< 7.2 or as defined by trial authors) · women for whom a decision had been made to deliver by caesarean section for suspected fetal distress based on FHR monitoring
Summary of findings for IV hexoprenaline showed no clear difference in umbilical artery pH < 7.2 compared with no tocolytic agent, whilst awaiting emergency delivery (low certainty).
1 finding from 1 review
Abnormal FHR as defined by trial authors (FHR tracing not improved) · women for whom a decision had been made to deliver by caesarean section for suspected fetal distress based on FHR monitoring
Summary of findings for IV hexoprenaline probably leads to lower FHR tracing not improved compared with no tocolytic agent, whilst awaiting emergency delivery (moderate certainty).
1 finding from 1 review
Proportion of patients who have no AOM recurrences at 6 months post‐randomisation
Grommets may leads to higher proportion of patients who have no AOM recurrences at 6 months… compared with active monitoring (low certainty).
1 finding from 1 review
Persistent tympanic membrane perforation
1 finding from 1 review
Proportion of patients who have no AOM recurrences at 12 months post‐randomisation
Grommets showed no clear difference in proportion of patients who have no AOM recurrences at 12 months… compared with active monitoring (low certainty).
1 finding from 1 review
Total number of AOM recurrences at 6 months post‐randomisation
Grommets showed no clear difference in total number of AOM recurrences at 6 months post‐randomisation compared with active monitoring (low certainty).
1 finding from 1 review
Total number of AOM recurrences at 12 months post‐randomisation
1 finding from 1 review
Disease‐specific quality of life
1 finding from 1 review
Awareness Postoperative interview · patients with prevention of recall of events during surgery
Anaesthesia depth monitors (BIS and M‐entropy) showed no clear difference in awareness Postoperative interview compared with standard clinical and electronic monitoring (low certainty).
1 finding from 1 review